Health Condition 1: null- Schizophrenia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Male or female between 18-45 years of age Meeting the DSM-5 clinical criteria for schizophrenia (APA, 2013) Patients currently stabilized on same antipsychotics for a period of at least 6 weeks Patients or primary caregiver with capacity and willingness to give informed consent. Both in-patients and out-patients Having basic familiarity & comfort with using computers Both Right and Left Handed Education up to Primary level
Exclusion criteria
Exclusion criteria: Presence of past or current co-morbid Axis I disorders including substance abuse/dependence (other than caffeine or nicotine) Any history of seizure EXCEPT those therapeutically induced by ECT History suggestive of any neurological or progressive neurological condition. Having Colour blindness or Blindness Hearing impairment Non-consenting individuals Visual or motor disability which may hinder use of computers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Cognitive function (Time Frame: At baseline, post-intervention and at 3 months follow up.) - Clinical improvement of cognitive symptoms relative to pre-treatment baseline (Time Frame: At baseline, post-intervention and at 3 months follow up). - WHODAS II (Time Frame: At baseline, post-intervention and at 3 months follow up). Timepoint: The short term effectiveness would be measured immediately after the completion of the rehabilitation program at 9 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical improvement of negative symptoms (PANSS) relative to pre-treatment baseline. Global clinical improvement on Clinical global Impression Timepoint: The short term effectiveness would be measured immediately after the completion of the rehabilitation program in the 9th week, after completion of the retraining. | — |
Countries
India
Contacts
All Indian Institute of Medical Sciences